Skip to main content

Unfortunately we don't fully support your browser. If you have the option to, please upgrade to a newer version or use Mozilla Firefox, Microsoft Edge, Google Chrome, or Safari 14 or newer. If you are unable to, and need support, please send us your feedback.

Elsevier
Publish with us

Translational and Applied Bioenergetics

Aim & scope

Translational and Applied Bioenergetics is a major new series of print and ebooks in life science and applied biomedical research reference literature. The series considers advances in bioenergetics research, with an emphasis on clinical and therapeutic opportunity.

Bioenergetics has driven emerging, impactful science during the past decade, moving the field into more practical and patient-oriented directions. This requires a better understanding of the etiology of impaired bioenergetics in various conditions and pathologies, a plethora of innovative diagnostic procedures from the subcellular level to the whole organism, and many authentic therapeutics designed to tackle poor energy metabolism. All medical and healthcare professionals, along with clinical scientists, require up-to-date information on bioenergetics from the bench to the bedside to keep healthcare delivery standards at high level.

Mitochondrial Transplantation and Transfer Cover

The Translational and Applied Bioenergetics series provides succinct discussion and analysis across the whole field of translational and applied bioenergetics, from fundamental aspects of mitochondrial energy metabolism and viability to clinical bioenergetics in various diseases and disease models, diagnostics approaches, and therapeutics. Early series volumes will discuss variations within these themes, including extramitochondrial bioenergetics, mitochondrial homeostasis, biogenesis and degradation, mitochondrial signalling and regulation, extracellular mitochondria, the mitochondrial genome, mitochondrial dysfunction, and metabolic flexibility, as well as volumes on bioenergetics across various disease types, diet and nutrition, developmental processes, and drug discovery.

Audience

Primary market/audience: Active researchers in biochemistry, molecular biology, cell biology, oncology, pharmacology; clinician scientists

Secondary market/audience: Students and clinicians

Series Editor

SOMP

Sergej Ostojic, MD, PhD

Professor of Nutrition

Department of Nutrition and Public Health, University of Agder

Read more about Sergej Ostojic, MD, PhD